The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018

The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018

Abstract The great debate session at the 2018 Melanoma Bridge congress (November 29–December 1, Naples, Italy) featured counterpoint views from experts on three topical issues in melanoma. These were whether overall survival should still be the main endpoint for clinical trials in melanoma, whether...

Full description

Bibliographic Details
Main Authors: Paolo A. Ascierto, Paolo Bruzzi, Alexander Eggermont, Omid Hamid, Hussein A. Tawbi, Alexander van Akkooi, Alessandro Testori, Corrado Caracò, Igor Puzanov, Francesco Perrone
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Journal of Translational Medicine
Subjects:
Melanoma
Immunotherapy
Anti-PD-1
Anti-CTLA-4
Targeted therapy
BRAF inhibitor
Online Access:http://link.springer.com/article/10.1186/s12967-019-1892-5

Internet

http://link.springer.com/article/10.1186/s12967-019-1892-5

Similar Items